Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Corrigendum: TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.

Chen X, Nie Y, Xiao H, Bian Z, Scarzello AJ, Song NY, Trivett AL, Yang, Oppenheim JJ.

Sci Rep. 2016 Oct 13;6:34680. doi: 10.1038/srep34680. No abstract available.

2.

TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.

Chen X, Nie Y, Xiao H, Bian Z, Scarzello AJ, Song NY, Trivett AL, Yang, Oppenheim JJ.

Sci Rep. 2016 Sep 7;6:32834. doi: 10.1038/srep32834. Erratum in: Sci Rep. 2016 Oct 13;6:34680.

3.

LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.

Scarzello AJ, Jiang Q, Back T, Dang H, Hodge D, Hanson C, Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout RH.

Gut. 2016 Oct;65(10):1765-75. doi: 10.1136/gutjnl-2014-308810. Epub 2015 Jul 23.

4.

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

Subleski JJ, Scarzello AJ, Alvord WG, Jiang Q, Stauffer JK, Kronfli A, Saleh B, Back T, Weiss JM, Wiltrout RH.

J Hepatol. 2015 Nov;63(5):1181-9. doi: 10.1016/j.jhep.2015.06.021. Epub 2015 Jul 2.

5.

IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Hodge DL, Berthet C, Coppola V, Kastenmüller W, Buschman MD, Schaughency PM, Shirota H, Scarzello AJ, Subleski JJ, Anver MR, Ortaldo JR, Lin F, Reynolds DA, Sanford ME, Kaldis P, Tessarollo L, Klinman DM, Young HA.

J Autoimmun. 2014 Sep;53:33-45. doi: 10.1016/j.jaut.2014.02.003. Epub 2014 Feb 28.

6.

Stat2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsis.

Alazawi W, Heath H, Waters JA, Woodfin A, O'Brien AJ, Scarzello AJ, Ma B, Lopez-Otalora Y, Jacobs M, Petts G, Goldin RD, Nourshargh S, Gamero AM, Foster GR.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8656-61. doi: 10.1073/pnas.1221652110. Epub 2013 May 7.

7.

Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.

Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH.

Hepatology. 2012 Oct;56(4):1567-74. doi: 10.1002/hep.25674. Epub 2012 Sep 11. Review.

8.

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH.

Cancer Res. 2011 Apr 1;71(7):2718-27. doi: 10.1158/0008-5472.CAN-10-2705. Epub 2011 Feb 15.

9.

TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.

Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH.

J Immunol. 2011 Jan 15;186(2):838-47. doi: 10.4049/jimmunol.1001735. Epub 2010 Dec 10.

10.

STAT2 contributes to promotion of colorectal and skin carcinogenesis.

Gamero AM, Young MR, Mentor-Marcel R, Bobe G, Scarzello AJ, Wise J, Colburn NH.

Cancer Prev Res (Phila). 2010 Apr;3(4):495-504. doi: 10.1158/1940-6207.CAPR-09-0105. Epub 2010 Mar 16.

11.

Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2.

Romero-Weaver AL, Wang HW, Steen HC, Scarzello AJ, Hall VL, Sheikh F, Donnelly RP, Gamero AM.

Mol Cancer Res. 2010 Jan;8(1):80-92. doi: 10.1158/1541-7786.MCR-08-0344. Epub 2010 Jan 12.

12.

Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.

Weiss JM, Back TC, Scarzello AJ, Subleski JJ, Hall VL, Stauffer JK, Chen X, Micic D, Alderson K, Murphy WJ, Wiltrout RH.

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19455-60. doi: 10.1073/pnas.0909474106. Epub 2009 Nov 5.

13.

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.

Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM.

Cancer Biol Ther. 2008 Jul;7(7):1109-15. Epub 2008 Apr 24.

14.

Interferon: cellular executioner or white knight?

Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM.

Curr Med Chem. 2007;14(12):1279-89. Review.

PMID:
17504213
15.

A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.

Scarzello AJ, Romero-Weaver AL, Maher SG, Veenstra TD, Zhou M, Qin A, Donnelly RP, Sheikh F, Gamero AM.

Mol Biol Cell. 2007 Jul;18(7):2455-62. Epub 2007 Apr 18.

16.

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.

Lifson JD, Rossio JL, Piatak M Jr, Bess J Jr, Chertova E, Schneider DK, Coalter VJ, Poore B, Kiser RF, Imming RJ, Scarzello AJ, Henderson LE, Alvord WG, Hirsch VM, Benveniste RE, Arthur LO.

AIDS Res Hum Retroviruses. 2004 Jul;20(7):772-87.

PMID:
15307924
17.

Mucosal challenge of Macaca nemestrina with simian immunodeficiency virus (SIV) following SIV nucleocapsid mutant DNA vaccination.

Gorelick RJ, Lifson JD, Yovandich JL, Rossio JL, Piatak M Jr, Scarzello AJ, Knott WB, Bess JW Jr, Fisher BA, Flynn BM, Henderson LE, Arthur LO, Benveniste RE.

J Med Primatol. 2000 Aug;29(3-4):209-19.

PMID:
11085583

Supplemental Content

Loading ...
Support Center